MorphoSys Exhibitor Theater: MONJUVI (tafasitamab-cxix) for injection, for intravenous use

Re-certification Units and Contact Hours will not be provided for this session.

Sally Y. Barbour, PharmD, BCOP, CPP

Duke University Hospital

Sally Barbour, PharmD, BCOP, CPP, is the Director of Oncology Pharmacy Programs and the Oncology Pharmacy Residency Program Director at Duke University Medical Center. Before taking on these leadership responsibilities, she served as a clinical oncology pharmacist for the Duke Comprehensive Cancer Center. Dr. Barbour co-founded the North Carolina Oncology Pharmacists Association in 2001 and co-plans their annual meeting. She has developed numerous supportive care guidelines at Duke and lectures on topics related to chemotherapy-induced nausea and vomiting, myelosuppression, general supportive care, lung cancer, oral chemotherapy, and the role of pharmacy in oncology practice.

Only available as part of a package

Key:

Complete
Failed
Available
Locked
Breakout Session
Live event: 09/10/2020 at 2:15 PM (EDT) You must register to access.
Session Evaluation
The purpose of the Education Program Evaluation is to enable INS to evaluate each educational session and provide feedback to the speaker. You must register to access.